Androstenedione treatment reduces loss of cancellous bone volume in ovariectomised rats in a dose-responsive manner and the effect is not mediated by oestrogen

Journal of Endocrinology

Volumn 156, Issue 2, 1998, Pages 331-339

  Lea, C K ^a   Moxham, V ^a   Reed, M J ^a   Flanagan, A M ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; ESTROGEN; ESTRONE; SEX HORMONE; TESTOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; BONE METABOLISM; CANCELLOUS BONE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; METAPHYSIS; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

ANDROSTENEDIONE; ANIMALS; BONE REMODELING; DELAYED-ACTION PREPARATIONS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; TESTOSTERONE;

EID: 0031905609     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1560331     Document Type: Article

References (20)

1. Andersson S 1995 17β-Hydroxysteroid dehydrogenase: isoenzymes and mutations. Journal of Endocrinology 146 197-200.
2. Cauley JA, Gutai JP, Sandler RB, LaPorte RE, Kuller LH & Sashin D 1986 The relationship of endogenous estrogen to bone density and bone area in normal postmenopausal women. American Journal of Epidemiology 124 752-761.
3. Colvard DSE, Eriksen EF, Keeting PE, Wilson EM, Lubahn DB, French FS, Riggs BL & Spelsberg TC 1989 Identification of androgen receptors in normal human osteoblast-like cells. Proceedings of the National Academy of Sciences of the USA 86 854-857.
4. Devogelaer JP, Crabbe J & Nagant de Deuxchaisnes C 1987 Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass. British Medical Journal 294 798-800.
5. Durbridge TC, Morris HA, Parsons AM, Parkinson IH, Moore IJ, Porter S, Need AG, Nordin BEC & Vernon-Roberts B 1990 Progressive bone loss in rats after adrenalectomy and oophorectomy. Calcified Tissue International 47 383-387.
6. Gallagher AC, Chambers TJ & Tobias JH 1996 Androgens contribute to the stimulation of cancellous bone formation by ovarian hormones in female rats. American Journal of Physiology 270 E407-E412.
7. Goulding A & Gold E 1993 Flutamide-mediated androgen blockade evokes osteopenia in the female rat. Journal of Bone and Mineral Research 8 763-769.
8. Kalu DN 1991 The ovariectomized rat model of postmenopausal bone loss. Bone and Mineral 15 175-192.
9. Kalu DN, Liu C-C, Hardin RR & Hollis BW 1989 The aged rat model of ovarian hormone deficiency bone loss. Endocrinology 124 7-16.
10. Lea C, Kendall N & Flanagan AM 1996 Casodex (a non-steroidal antiandrogen) reduces cancellous, endosteal and periosteal bone formation in estrogen-replete female rats. Calcified Tissue International 58 268-272.
11. Marshall DH, Crilly RG & Nordin BEC 1977 Plasma androstenedione and oestrone levels in normal and osteoporotic postmenopausal women. British Medical Journal 2 1177-1179.
12. Ousler MJ, Riggs BL & Spelsberg TC 1993 Androgen action on avian osteoclasts and human giant cell tumours of the bone. Journal of Bone and Mineral Research 8 (Suppl 1) S387.
13. Parfitt AM, Matthews CHE, Villeneuve AR & Kleerekoper M 1983 Relationships between surface, volume and thickness of iliac trabecular bone in ageing and in osteoporosis. Journal of Clinical Investigation 72 1396-1409.
14. Schmidt WG & Katzenellenbogen BS 1979 Androgen-uterine interactions: an assessment of androgen interaction with the testosterone- and estrogen-receptor systems and stimulation of uterine growth and progesterone-receptor synthesis. Molecular and Cellular Endocrinology 15 91-108.
15. Steiniche T, Hasling C, Charles P, Eriksen EF, Mosekilde L & Melsen F 1989 A randomised study on the effects of estrogen/ gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis. Bone 10 313-320.
16. Tobias JH, Gallagher A & Chambers TJ 1994 5α-Dihydrotestosterone partially restores cancellous bone volume in osteopenic ovariectomized rats. American Journal of Physiology 267 E853-E859.
17. Turner RT, Lifrak ER, Beckner M, Wakley GK, Hannon KS & Parker LN 1990 Dehydroepiandrosterone reduces cancellous bone osteopenia in ovariectomized rats. American Journal of Physiology 258 E673-E677.
18. Wakely GK, Schutte HD, Hannon KS & Turner RT 1991 Androgen treatment prevents loss of cancellous bone in the orchidectomized rat. Journal of Bone and Mineral Research 6 325-329.
19. Wronski TJ, Cintron M & Dann LM 1988a Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcified Tissue International 43 179-183.
20. Wronski TJ, Cintron M, Doherty AL & Dann LM 1988b Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123 681-686.